(Tongue-in-cheek, of course…)
Greetings Investors!
As mentioned early on in THIS NEW VIDEO UPDATE, I’ll have something to say around week’s end or so about our new so-called Liberation Day. It would be nice if we were celebrating being liberated from bloated government; that’s not to be either, as I’ll also sadly be recounting shortly.
In the video I discuss a few subjects/updates as follows:
-> Ecuador’s looming election (which, no matter the winner, shouldn’t unduly affect the mining industry in a negative way)
-> Salazar Resources’ now-under construction (by senior partner and operator Silvercorp) El Domo Project.
HERE is a conversation with Pres. Lon Shaver about the progress ahead of planned first production in 2026.
And if you missed it previously, HERE is Silvercorp’s Jan. 7 news outlining the beginning of construction.
-> BacTech Environmental
HERE is CEO Ross Orr’s “Sunday Morning Coffee” from last weekend, with a link to Dr. Paul Miller’s work.
And HERE is his email from yesterday, highlighting coverage in Northern Ontario Business.
-> Biotech stocks were beaten up anew early on this week, following Dr. Peter Marks’ departure from the FDA and an overreaction (I.M.O.) to that, staff cuts and more.
RIGHT HERE you can listen to this morning’s interview of Bush, Jr. FDA Commish Dr. Mark McClellan on this.
-> I opine on Sarepta Therapeutics being a great BUY once again, as its share price beating was a specific overreaction to its latest news.
All the best,
Chris Temple
Editor/Publisher
Wednesday — April 2, 2025
Don’t forget that you can follow my thoughts, focus and all pretty much daily ! ! !
* On Twitter, at https://twitter.com/NatInvestor
* On Facebook at https://www.facebook.com/TheNationalInvestor
* On Linked In at https://www.linkedin.com/in/chris-temple-1a482020/
* On my You Tube channel, at https://www.youtube.com/c/ChrisTemple (MAKE SURE TO SUBSCRIBE!)
When you join me, among the many things you’ll be entitled to is my “Members Handbook.” It crystallizes my approach to the markets…asset allocation recommendations… how I select individual companies…and a LOT more.
